Eight-year follow-up of a girl with McCune-Albright syndrome
- PMID: 21448334
- PMCID: PMC3065316
- DOI: 10.4274/jcrpe.v3i1.09
Eight-year follow-up of a girl with McCune-Albright syndrome
Abstract
McCune-Albright syndrome (MAS) is characterized by the triad of fibrous dysplasia (FD), cafe-au-lait spots and precocious puberty (PP). We report a 14-year-old girl with MAS who has been followed-up for 8 years. She was referred for multiple fractures and vaginal bleeding at age 5.9 years. She had peripheral PP, FD, and osteoporosis and was diagnosed as MAS. The patient was treated with aromatase inhibitors and bisphosphonates. She had no menses during aromatase inhibitor treatment. Her growth rate and bone maturation were in normal ranges while on treatment. She had one new fracture on the seventh year of follow- up in spite of bisphosphonate treatment.
Keywords: McCune-Albright syndrome; aromatase inhibitor; bisphosphonate; follow-up.
©Journal of Clinical Research in Pediatric Endocrinology, Published by Galenos Publishing.
Similar articles
-
Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.J Pediatr Adolesc Gynecol. 2012 Feb;25(1):e9-e13. doi: 10.1016/j.jpag.2011.09.005. Epub 2011 Nov 3. J Pediatr Adolesc Gynecol. 2012. PMID: 22051789
-
[Precocious puberty in the McCune-Albright Syndrome: a case report].Pan Afr Med J. 2025 May 26;51:20. doi: 10.11604/pamj.2025.51.20.44747. eCollection 2025. Pan Afr Med J. 2025. PMID: 40727519 Free PMC article. French.
-
McCune-Albright syndrome.Orphanet J Rare Dis. 2008 May 19;3:12. doi: 10.1186/1750-1172-3-12. Orphanet J Rare Dis. 2008. PMID: 18489744 Free PMC article.
-
Tamoxifen improved final height prediction in a girl with McCune-Albright syndrome: patient report and literature review.J Pediatr Endocrinol Metab. 2006 Jan;19(1):81-6. doi: 10.1515/jpem.2006.19.1.81. J Pediatr Endocrinol Metab. 2006. PMID: 16509532 Review.
-
[McCune-Albright syndrome: a case report and literature review].Pan Afr Med J. 2023 Sep 22;46:33. doi: 10.11604/pamj.2023.46.33.35274. eCollection 2023. Pan Afr Med J. 2023. PMID: 38145201 Free PMC article. Review. French.
Cited by
-
Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.Br J Clin Pharmacol. 2019 Jun;85(6):1169-1179. doi: 10.1111/bcp.13820. Epub 2018 Dec 25. Br J Clin Pharmacol. 2019. PMID: 30471134 Free PMC article. Review.
References
-
- Zacharin M MBBS; FRACP. The spectrum of McCune Albright Syndrome. Pediatr Endocrinol Rev. 2007;4:412–418. - PubMed
-
- Völkl TM, Dörr HG. McCune- Albright Syndrome: Clinical Picture and Natural History in Children and Adolescents. J Pediatr Endocrinol Metab. 2006;19:551–559. - PubMed
-
- Siadati S, Shafigh E. McCune-Albright Syndrome: A case report. Arch Iran Med. 2010;13:245–247. - PubMed
-
- Weinstein LS. Gs_ Mutations in Fibrous Dysplasia and McCune-Albright Syndrome. J Bone Miner Res. 2007;21 [Suppl]:P120–4. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous